NVAX · Novavax Inc · Investor Relations
$7.91
-0.06 (-0.69%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$1.31B
Shares
165.01M
Volume · Nov 19
1.15M
Avg daily vol (3M)
6.86M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-17 | Jefferies London Healthcare Conference | Conference |
| 2026-11-05 | Novavax Inc Q3 FY2026 Earnings Call | Earnings call |
| 2026-11-05 | Novavax Inc Q3 FY2026 Earnings Call | Earnings call |
| 2026-09-10 | Citi’s 2026 BioPharma Back to School Conference | Conference |
| 2026-09-09 | 2026 Cantor Global Healthcare Conference | Conference |
| 2026-08-06 | Novavax Inc Q2 FY2026 Earnings Call | Earnings call |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-13 | Bank of America Securities 2026 Healthcare Conference | Conference |
| 2026-05-06 | Novavax Inc Q1 FY2026 Earnings Call | Earnings call |
| 2026-03-11 | Jefferies Biotech on the Beach Summit | Event |
| 2026-03-10 | Leerink Partners 2026 Global Healthcare Conference | Conference |
| 2026-03-03 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-26 | Novavax Inc Q4 FY2025 Earnings Call | Earnings call |
| 2026-01-14 | Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-11-19 | Jefferies London Healthcare Conference | Conference |
| 2025-11-06 | Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 | Event |
| 2025-09-04 | Novavax to Participate in the Cantor Global Healthcare Conference | Conference |
| 2025-08-06 | Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 | Event |
Source: https://ir.novavax.com/
Key facts
CIK
1000694
CUSIP
670002401
13F (30d)
290 filings
249 filers
Visit website
Investor relations